A new therapy in Epstein-Barr virus-associated lymphoproliferative disease: a case report and a revision of the literature

A new therapy in Epstein-Barr virus-associated lymphoproliferative disease: a case report and a revision of the literature

Abstract Background Systemic chronic active Epstein-Barr virus infection is an extremely rare childhood disease. Since chronic active Epstein-Barr virus infection can trigger the onset of Epstein-Barr virus-associated lymphoproliferative disease. The clinical manifestations of the disease vary accor...

Full description

Bibliographic Details
Main Authors: Lingling Xu, Hongjun Ba, Hongrong Lin, Liangying Zhong, Suping Li, Wen Tang, Zhiyong Ke, Ziyin Ye
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Italian Journal of Pediatrics
Subjects:
Chronic active Epstein-Barr virus infection
Thalidomide
Propranolol
Enteritis
Encephalitis
Vascular lesions
Online Access:http://link.springer.com/article/10.1186/s13052-019-0741-8

Internet

http://link.springer.com/article/10.1186/s13052-019-0741-8

Similar Items